The global pharmaceutical industry continues to evolve with rising demand for respiratory disease treatments and improved pulmonary care solutions. Aminophylline remains an important therapeutic compound widely used in the treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and bronchospasm. Increasing respiratory health concerns, growing pollution...

The global respiratory tract infection treatment market is experiencing steady growth due to the rising prevalence of respiratory infections, increasing air pollution levels, growing geriatric population, and continuous advancements in pharmaceutical therapies. Respiratory tract infections (RTIs) affect millions of individuals worldwide and include conditions such as bronchitis, pneumonia,...